Business Wire

Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial Failure Rate

95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind ...

U.S. labs are keeping human brains “alive” outside the body to test Alzheimer’s and Parkinson’s drugs, and the twist is that the science instantly collides with the one ...

Human brains donated after death are being kept biologically active in a Connecticut lab, where scientists are using them to ...
The Hill

Cutting animal testing will jeopardize human health

The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals ...
GEN

Vivodyne’s Lab Grown Human Tissue Platform Gets Real with $38 Million Seed Financing

Andrei Georgescu, PhD, CEO of Vivodyne, was hoping to couple his interests in science and engineering when he chose UPenn for his graduate research. His goal was to build on his background in ...